SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO RULES 13d-1(b) AND (c)
AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
THE INFORMATION REQUIRED IN THE REMAINDER OF THIS COVER PAGE SHALL NOT BE
DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES
EXCHANGE ACT OF 1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT
SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT.
ASCENT PEDIATRICS, INC.
(NAME OF ISSUER)
Common Stock ($.01 par value)
(TITLE OF CLASS OF SECURITIES)
(CUSIP NUMBER)
00004362X1
<PAGE>
CUSIP No. 0008523811 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Compagnie Financiere de Paribas
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON _______________
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Republic of France
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED 5 SOLE VOTING POWER -0-<F1>
BY EACH REPORTING PERSON WITH ---------------------------------------
6 SHARED VOTING POWER -0-
---------------------------------------
7 SOLE DISPOSITIVE
POWER -0-<F1>
---------------------------------------
8 SHARED DISPOSITIVE
POWER -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-0-<F1>
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES ( )
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
-0-<F1>
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
- --------------------------------------------------------------------------------
<F1> Compagnie Financiere de Paribas may be deemed to be the beneficial owner of
the common stock of Ascent Pediatrics, Inc. reported herein through its
ownership of Banque Paribas. Such shares of Ascent Pediatrics, Inc. common stock
are not included above so as to avoid double counting.
<PAGE>
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Banque Paribas
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON _______________
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Republic of France
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED 5 SOLE VOTING POWER 10,200<F2>
BY EACH REPORTING PERSON WITH ---------------------------------------
6 SHARED VOTING POWER -0-
---------------------------------------
7 SOLE DISPOSITIVE
POWER 10,200<F2>
---------------------------------------
8 SHARED DISPOSITIVE
POWER -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,200<F2>
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES ( )
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.1<F3>
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
BK
- --------------------------------------------------------------------------------
<F2> Represents warrants to purchase common stock.
<F3> Percentage includes shares held by Paribas Principal Incorporated reported
herein because Paribas Principal Incorporated is a wholly-owned subsidiary of
Banque Paribas.
<PAGE>
CUSIP No. 0008523811 13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Paribas Principal Incorporated
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON _______________
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ( )
(b) (X)
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED 5 SOLE VOTING POWER 549,229<F4>
BY EACH REPORTING PERSON WITH ---------------------------------------
6 SHARED VOTING POWER -0-
---------------------------------------
7 SOLE DISPOSITIVE
POWER 549,229<F4>
---------------------------------------
8 SHARED DISPOSITIVE
POWER -0-
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
549,229<F4>
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES ( )
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
8.1%<F5>
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
OO
- --------------------------------------------------------------------------------
<F4> Includes 156,922 shares issuable upon the exercise of warrants.
<F5> Percentage includes shares held by Banque Paribas reported herein because
Paribas Principal Incorporated is a wholly-owned subsidiary of Banque Paribas.
<PAGE>
SCHEDULE 13G
Item 1(a). Name of Issuer:
Ascent Pediatrics, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
187 Ballardvale Street
Suite B125
Wilmington, MA 01887
Item 2(a). Name of Person Filing:
Compagnie Financiere de Paribas
Item 2(b). Address of Principal Business Office or, if None, Residence:
787 Seventh Avenue
New York, NY 10019
Item 2(c). Citizenship:
French
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
00004362X1
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
0<F6>
(b) Percent of class:
0<F6>
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
0<F6>
(ii) Shared power to vote or to direct the vote:
0
<PAGE>
(iii) Sole power to dispose or to direct the
disposition of:
0<F6>
(iv) Shared power to dispose or to direct the
disposition of:
0.
<F6> Compagnie Financiere de Paribas may be deemed to be the beneficial owner of
the common stock of Ascent Pediatrics, Inc. reported herein through its
ownership of Banque Paribas. Such shares of Ascent Pediatrics, Inc. common stock
are not included above so as to avoid double counting.
Item 5. Not applicable
Item 6. Not applicable
Item 7. Not applicable
Item 8. Not applicable
Item 9. Not applicable
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
Item 1(a). Name of Issuer:
Ascent Pediatrics, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
187 Ballardville Street
Suite B125
Wilmington, MA 01887
Item 2(a). Name of Person Filing:
Banque Paribas
Item 2(b). Address of Principal Business Office or, if None, Residence:
787 Seventh Avenue
New York, NY 10019
Item 2(c). Citizenship:
French
<PAGE>
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
00004362X1
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
10,200<F7>
(b) Percent of class:
8.1%<F8>
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the
vote:
10,200<F7>
(ii) Shared power to vote or to direct the
vote:
0
(iii) Sole power to dispose or to direct the
disposition of:
10,200<F7>
(iv) Shared power to dispose or to direct
the disposition of:
0.
<F7> Represents warrants to purchase common stock.
<F8> Percentage includes shares held by Paribas Principal Incorporated reported
herein because Paribas Principal Incorporated is a wholly-owned subsidiary of
Banque Paribas.
Item 5. Not applicable
Item 6. Not applicable
Item 7. Not applicable
Item 8. Not applicable
Item 9. Not applicable
Item 10. Certification.
<PAGE>
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
SCHEDULE 13G
Item 1(a). Name of Issuer:
Ascent Pediatrics, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
187 Ballardvale Street
Suite B125
Wilmington, MA 01887
Item 2(a). Name of Person Filing:
Paribas Principal Incorporated
Item 2(b). Address of Principal Business Office or, if None, Residence:
787 Seventh Avenue
New York, NY 10019
Item 2(c). Citizenship:
New York
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
00004362X1
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
549,229<F9>
(b) Percent of class:
8.1%<F10>
<PAGE>
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
549,229<F9>
(ii) Shared power to vote or to direct the
vote:
0
(iii) Sole power to dispose or to direct the
disposition of:
0<F9>
(iv) Shared power to dispose or to direct
the disposition of:
0.
<F9> Includes 156,922 shares of issuable upon the exercise of warrants.
<F10> Percentage includes shares held by Banque Paribas reported herein because
Paribas Principal Incorporated is a wholly-owned subsidiary of Banque Paribas.
Item 5. Not applicable
Item 6. Not applicable
Item 7. Not applicable
Item 8. Not applicable
Item 9. Not applicable
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
COMPAGNIE FINANCIERE de PARIBAS
By: /s/ Herve Couffin
----------------------------------
Name: Herve Couffin
Title: Directoire
BANQUE PARIBAS
By: /s/ Stephen Eisenstein
----------------------------------
Name: Stephen Eisenstein
Title: Partner
PARIBAS PRINCIPAL INCORPORATED
By: /s/ Gary Binning
----------------------------------
Name: Gary Binning
Title: Director
